With bta798 in a large phaseIIb trial it's worth looking again at the market size of the cOmmon cold. It's massive!! Perhaps bigger than the flu.
I wonder if bta798 could be made available over the counter.
In the United States, the common cold leads to 75 to 100 million physician visits annually at a conservative cost estimate of $7.7 billion per year. Americans spend $2.9 billion on over-the-counter drugs and another $400 million on prescription medicines for symptomatic relief.[57][68]
More than one-third of patients who saw a doctor received an antibiotic prescription, which has implications for antibiotic resistance from overuse of such drugs.[68]
An estimated 22 to 189 million school days are missed annually due to a cold. As a result, parents missed 126 million workdays to stay home to care for their children. When added to the 150 million workdays missed by employees suffering from a cold, the total economic impact of cold-related work loss exceeds $20 billion per year.[10][57][68] This accounts for 40% of time lost from work.[69]
BTA Price at posting:
$1.41 Sentiment: Buy Disclosure: Held
